Key result
The ACE I/D genotype was associated with a significantly higher risk of type 2 diabetes mellitus in an Iranian population (OR 10; 95% CI 3.7 to 27; p<0.0001).
Why the study?
The study aimed to examine the relationship between type 2 diabetes mellitus and renin-angiotensin system gene polymorphisms in the Iranian population.
Does the ACE I/D gene polymorphism increase the risk of type 2 diabetes mellitus in an Iranian population?
Case-Control (n=100)
Does the ACE I/D gene polymorphism increase the risk of type 2 diabetes mellitus in an Iranian population?
Odds Ratio: 10 (95% CI 3.7–27)
p-value: p=<0.0001
The ACE I/D genotype and D allele are strongly associated with an increased risk of type 2 diabetes mellitus in the Iranian population.
This study aimed to examine the relationship between type 2 diabetes mellitus (T2DM) and renin-angiotensin system gene polymorphisms in the Iranian population. Additionally, we performed a straightforward meta-analysis of the present articles to better understand this role. A total of 100 Iranian individuals, 50 patients with T2DM, and 50 age-matched healthy individuals were included in this study. DNA was extracted using the salting-out approach, polymerase chain reaction was used to amplify the angiotensin-converting enzyme (ACE) gene, electrophoresis techniques were used, and genotyping was performed. We also searched PubMed, Web of Science, Scopus, and Google Scholar databases for papers published in 2023. We found a significantly higher frequency of I/D genotype in the patient group than in the control group, and the risk of T2DM was 10 times higher in individuals with the I/D genotype (OR, 10 [95% CI, 3.7 to 27]; p < 0.0001) and also 2.85 time higher in individuals with the D allele OR, 2.85 [95% CI, 1.55 to 5.24]; p < 0.001). The ACE polymorphism alleles D and I/D genotypes may increase the risk of developing T2DM in an Iranian population.
No takes yet. Share an insight, caveat, or question.
Momeni‐Moghaddam et al. (2024) conducted a case-control in Type 2 diabetes mellitus (n=100). ACE I/D genotype vs. Without I/D genotype was evaluated on Type 2 diabetes mellitus (OR 10, 95% CI 3.7 to 27, p=<0.0001). The ACE I/D genotype was associated with a significantly higher risk of type 2 diabetes mellitus in an Iranian population (OR 10; 95% CI 3.7 to 27; p<0.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: